Cotinga Pharmaceuticals Inc COTQF

Healthcare Biotechnology

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.

GREY:COTQF - Post by User

Cotinga Pharmaceuticals Inc

Bullboard Posts

Comment by attila9on Feb 02, 2004 9:22am

166 Views

Post# 6987970

RE: Securities Commission

Listen yourself you f##cking bonehead.I don't use a broker i use TD waterhouse to buy this kind of speculative stock.I know CIBC Mellon does the mailing it's on sedar.It's not the AGM i'm disputing it's the lack of notification & proxy mailing.COT must provide a list of shareholders to cibc mellon for mailing purposes.And i also believe your full of crap you never recieved yours either & once again are trying to cover up the incompetence of this company.If your going to try & make yourself out be be the guru of stock trading then why not take the time to ask if i use a broker before you shoot your big f##king trap off.We all know who you are & post under more than one name so go crawl back under the rock you came out from.And yes before you post it i also use two named but i have had the balls to post it up front.Now go back to sleep you moron you.JMHO A33Hole

Bullboard Posts

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity